|
1
|
Takahashi I, Matsusaka T, Onohara T, et
al: Clinicopathological features of long-term survivors of
scirrhous gastric cancer. Hepatogastroenterology. 47:1485–1488.
2000.PubMed/NCBI
|
|
2
|
Ito S, Nakanishi H, Kodera Y, Mochizuki Y,
Tatemastu M and Yamamura Y: Prospective validation of quantitative
CEA mRNA detection in peritoneal washes in gastric carcinoma
patients. Br J Cancer. 93:986–992. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bonenkamp JJ, Songun I, Hermans J and van
de Velde CJ: Prognostic value of positive cytology findings from
abdominal washings in patients with gastric cancer. Br J Surg.
83:672–674. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kodera Y, Nakanishi H, Yamamura Y, et al:
Prognostic value and clinical implications of disseminated cancer
cells in the peritoneal cavity detected by reverse
transcriptase-polymerase chain reaction and cytology. Int J Cancer.
79:429–433. 1998. View Article : Google Scholar
|
|
5
|
Fujii S, Kitayama J, Kaisaki S, et al:
Carcinoembryonic antigen mRNA in abdominal cavity as a useful
predictor of peritoneal recurrence of gastric cancer with serosal
exposure. J Exp Clin Cancer Res. 21:547–553. 2002.PubMed/NCBI
|
|
6
|
Tokuda K, Natsugoe S, Nakajo A, et al:
Clinical significance of CEA-mRNA expression in peritoneal lavage
fluid from patients with gastric cancer. Int J Mol Med. 11:79–84.
2003.PubMed/NCBI
|
|
7
|
Boku T, Nakane Y, Minoura T, et al:
Prognostic significance of serosal invasion and free
intraperitoneal cancer cells in gastric cancer. Br J Surg.
77:436–439. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kodera Y, Nakanishi H, Ito S, et al:
Quantitative detection of disseminated free cancer cells in
peritoneal washes with real-time reverse transcriptase-polymerase
chain reaction: a sensitive predictor of outcome for patients with
gastric carcinoma. Ann Surg. 235:499–506. 2002. View Article : Google Scholar
|
|
9
|
Oyama K, Terashima M, Takagane A, Maesawa
C, et al: Prognostic significance of peritoneal minimal residual
disease in gastric cancer detected by reverse
transcription-polymerase chain reaction. Br J Surg. 91:435–443.
2004. View
Article : Google Scholar
|
|
10
|
Zeimet AG, Widschwendter M, Knabbe C, et
al: Ascitic interleukin-12 is an independent prognostic factor in
ovarian cancer. J Clin Oncol. 16:1861–1868. 1998.PubMed/NCBI
|
|
11
|
Majima T, Ichikura T, Seki S, Takayama E,
Hiraide H and Mochizuki H: Interleukin-10 and interferon-gamma
levels within the peritoneal cavity of patients with gastric
cancer. J Surg Oncol. 78:124–130. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang B, Rong G, Wei H, et al: The
prevalence of Th17 cells in patients with gastric cancer. Biochem
Biophys Res Commun. 374:533–537. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maruyama T, Kono K, Mizukami Y, et al:
Distribution of Th17 cells and FoxP3(+) regulatory T cells in
tumor-infiltrating lymphocytes, tumor-draining lymph nodes and
peripheral blood lymphocytes in patients with gastric cancer.
Cancer Sci. 101:1947–1954. 2010.
|
|
14
|
Miyahara Y, Odunsi K, Chen W, Peng G,
Matsuzaki J and Wang RF: Generation and regulation of human
CD4+ IL-17-producing T cells in ovarian cancer. Proc
Natl Acad Sci USA. 105:15505–15510. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Langowski JL, Zhang X, Wu L, et al: IL-23
promotes tumour incidence and growth. Nature. 442:461–465. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kato T, Furumoto H, Ogura T, et al:
Expression of IL-17 mRNA in ovarian cancer. Biochem Biophys Res
Commun. 282:735–738. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sfanos KS, Bruno TC, Maris CH, et al:
Phenotypic analysis of prostate-infiltrating lymphocytes reveals
TH17 and Treg skewing. Clin Cancer Res.
14:3254–3261. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Numasaki M, Fukushi J, Ono M, et al:
Interleukin-17 promotes angiogenesis and tumor growth. Blood.
101:2620–2627. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Benchetrit F, Ciree A, Vives V, et al:
Interleukin-17 inhibits tumor cell growth by means of a
T-cell-dependent mechanism. Blood. 99:2114–2121. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zou W and Restifo NP: T(H)17 cells in
tumour immunity and immunotherapy. Nat Rev Immunol. 10:248–256.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iida T, Iwahashi M, Katsuda M, et al:
Tumor-infiltrating CD4+ Th17 cells produce IL-17 in
tumor microenvironment and promote tumor progression in human
gastric cancer. Oncol Rep. 25:1271–1277. 2011.
|
|
22
|
Kryczek I, Wei S, Zou L, et al: Cutting
edge: Th17 and regulatory T cell dynamics and the regulation by
IL-2 in the tumor microenvironment. J Immunol. 178:6730–6733. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lissoni P, Mandalà M, Curigliano G, et al:
Progress report on the palliative therapy of 100 patients with
neoplastic effusions by intracavitary low-dose interleukin-2.
Oncology. 60:308–312. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lenzi R, Rosenblum M, Verschraegen C, et
al: Phase I study of intraperitoneal recombinant human interleukin
12 in patients with Müllerian carcinoma, gastrointestinal primary
malignancies, and mesothelioma. Clin Cancer Res. 8:3686–3695.
2002.PubMed/NCBI
|
|
25
|
Fu QG, Meng FD, Shen XD and Guo RX:
Efficacy of intraperitoneal thermochemotherapy and immunotherapy in
intraperitoneal recurrence after gastrointestinal cancer resection.
World J Gastroenterol. 8:1019–1022. 2002.
|
|
26
|
Ye ZJ, Zhou Q, Gu YY, et al: Generation
and differentiation of IL-17-producing CD4+ T cells in
malignant pleural effusion. J Immunol. 185:6348–6354. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Derhovanessian E, Adams V, Hähnel K, et
al: Pretreatment frequency of circulating IL-17+
CD4+ T-cells, but not Tregs, correlates with clinical
response to whole-cell vaccination in prostate cancer patients. Int
J Cancer. 125:1372–1379. 2009.PubMed/NCBI
|
|
28
|
Kryczek I, Banerjee M, Cheng P, et al:
Phenotype, distribution, generation, and functional and clinical
relevance of Th17 cells in the human tumor environments. Blood.
114:1141–1149. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang JP, Yan J, Xu J, et al: Increased
intratumoral IL-17-producing cells correlate with poor survival in
hepatocellular carcinoma patients. J Hepatol. 50:980–989. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu J, Duan Y, Cheng X, et al: IL-17 is
associated with poor prognosis and promotes angiogenesis via
stimulating VEGF production of cancer cells in colorectal
carcinoma. Biochem Biophys Res Commun. 407:348–354. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhuang Y, Peng LS, Zhao YL, Shi Y, Mao XH,
et al: CD8+T cells that produce interleukin-17 regulate
myeloid-derived suppressor cells and are associated with survival
time of patients with gastric cancer. Gastroenterology.
143:951.e8–962.e8. 2012.PubMed/NCBI
|
